Fortis Surgical, LLC
$45.6K 464 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Microline Surgical Inc
Microline Surgical Inc reported $45,648.55 across General Payments, Research, and Ownership to 171 physicians and teaching hospitals across 171 transactions.
- $45.6K
- All-tracks total
- 171
- Transactions
- 171
- Recipients
- −$27.9K
- General Payments vs PY2023
Microline Surgical Inc reported $45,648.55 across all CMS Open Payments tracks (General + Research + Ownership) to 171 physicians and teaching hospitals in Program Year 2024 - ranking #1374 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $45,648.55, averaging $266.95 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer microline-surgical-inc Microline Surgical Inc
$45.6K · #1374/1,925 · 0.0% industry · PY2024
- TOT $45.6K
- RANK #1374
- SHARE 0.0%
- TXN 171
- RCP 171
- CAT 3
- GEN $45.6K
- ΔGEN −$27.9K
- TOP1 36.1%
- PY 2024
Volume peers
Nearest volume peer: Fortis Surgical, LLC ($45.6K)
Microline Surgical Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Microline Surgical Inc's CMS-reported General Payments decreased by $27.9K (−38.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MICROLINE SURGICAL INCPY2023: MICROLINE SURGICAL INCPY2024: Microline Surgical Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $73,590.85
- PY2024
- $45,648.55
What the Data Shows for Microline Surgical Inc
Rank #1374 of 1,925 companies in CMS Open Payments for 2024 belongs to Microline Surgical Inc, which reported $45,648.55 across 171 transactions to 171 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $266.95 per transaction and $266.95 per recipient.
The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Long-Term Medical Supply or Device Loan" at $25.4K, accounting for 55.7% of this company's General Payments and 61 transactions.
General Payment Breakdown by Type
"Long-Term Medical Supply or Device Loan" leads Microline Surgical Inc's 3-category general-payment breakdown at $25.4K, 55.7% of the reported total.
How Microline Surgical Inc divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Long-Term Medical Supply or Device Loan | $25.4K | 61 | 55.7% |
| Consulting Fee | $18.2K | 4 | 39.9% |
| Food and Beverage | $2.0K | 106 | 4.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $41,688.88 (91.3%) of $45,648.55 in this company's General Payments records across 88 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Microline Surgical Inc
The five named recipients with the highest reported General Payments from this company
- 1
Cambridge Health Alliance
$16,483.27 across 21 reported transactions
- 2
Chintan Patel
$9,900.00 across 2 reported transactions
- 3
Dmitry Nepomnayshy
$8,325.00 across 2 reported transactions
- 4
Upmc - Presbyterian Shadyside
$6,649.01 across 15 reported transactions
- 5
Methodist H/C Memphis Hospt.
$331.60 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Microline Surgical Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Microline Surgical Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Microline Surgical Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Hartmann USA, Inc.
$45.9K 479 recipients
Compare payment profiles
Mercator MedSystems, Inc.
$45.4K 12 recipients
Compare payment profiles
Curium US LLC
$45.9K 103 recipients
Compare payment profiles
AnX Robotica Corp
$45.9K 69 recipients
Compare payment profiles
Meisinger USA, LLC
$46.0K 358 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.